Elrig

AUGUST 8, 2025

Getting internal support to attend Drug Discovery 2025 We know it’s not always easy to step away from the lab or your desk, even when the event is free. That’s why we’ve put together this short guide (plus a helpful email template) to support you in getting the time and sign-off to attend Drug Discovery 2025 this October.

International

Science Daily: Pharmacology News

JUNE 12, 2025

This surprising discovery opens the door to understanding how cells might organize internal processes without membranes. Scientists have uncovered a previously unknown type of molecular motion inside DNA-based droplets: instead of spreading randomly, guest molecules advance in an organized wave.

DNA

Drug Target Review

DECEMBER 6, 2024

Based in South Africa, she has worked extensively with international biotech companies, specialising in therapeutic development for aging-related diseases and complex conditions such as glioblastoma and Autosomal Dominant Polycystic Kidney Disease (ADPKD).

RNA

Perficient: Drug Development

JULY 8, 2025

That means breaking down internal silos, politics, and bureaucracy. The report suggests that aligning these teams around shared goals and metrics is essential for success and the ability to deliver seamless, personalized experiences. Monaghan says, “Organizations must continue to view everything through the lens of the customer.

Marketing

Drug Patent Watch

DECEMBER 30, 2024

Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis. Understanding the key aspects of the regulatory framework and staying up-to-date with the latest developments is crucial for companies seeking to enter the Japanese market. References Tanaka, M., Freyr Solutions.

Drug Development

Drug Target Review

OCTOBER 30, 2024

About the author Anirban Datta, Head of Discovery Biology at Verseon International Corporation Anirban Datta PhD is the head of discovery biology at Verseon International Corporation. Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell. 2013;13(6):734-44.

Treatment

Drug Patent Watch

DECEMBER 10, 2024

Accelerated Time to Market : By leveraging a connected network of internal experts, integrated CDMOs can help eliminate downtime, optimize processes, and minimize errors, ultimately accelerating time to market.

Drug Development

LifeSciVC

MAY 14, 2025

Research continued through the 90s on the Space Shuttle, but only after the 1998 launch of the International Space Station (ISS) did microgravity research achieve sufficient scale and consistency for substantial progress to made in unraveling gravitys effects on molecular and cellular biology. Space.com, 17 Aug. Reichert, Paul et al.

Science

PPD

OCTOBER 31, 2024

These internal issues are compounded by external pressures like inflation, the development of innovative therapies that require complex protocols and the need to comply with shifting regulatory requirements.

Drug Development

Drug Target Review

JANUARY 14, 2025

Based in South Africa, she has worked extensively with international biotech companies, specialising in therapeutic development for ageing-related diseases and complex conditions such as glioblastoma and autosomal dominant polycystic kidney disease (ADPKD).

Drugs

The Pharma Data

JUNE 16, 2025

TEV-56278 is a first-in-class anti-PD1-IL2 ATTENUKINE therapy designed by Teva’s internal team of innovative scientists. The candidate utilizes a unique delivery platform (ATTENUKINE) to enable more potent and selective delivery of IL-2 directly to PD-1+ T-cells within the tumor microenvironment.

Therapies

Drug Target Review

FEBRUARY 10, 2025

We believed the missing piece was essentially an internal biotech at MD Anderson – one that could collaborate with researchers to industrialise their processes for cell therapies. Over the years, Ive had the privilege of working on more than 25 different products, Bock shared.

Therapies

Drug Target Review

APRIL 7, 2025

International Journal of Molecular Sciences. Silver Spring (MD): Food and Drug Administration (US); 2016-. Co-published by National Institutes of Health (US), Bethesda (MD). Bagyinszky E, et al. Transcriptomics in Alzheimers Disease: Aspects and Challenges. 21(10):3517.

Clinical Development

Drug Patent Watch

DECEMBER 10, 2024

Understanding Patent Thickets: A Global Challenge Before we dive into the international landscape of patent thickets, let’s first grasp what they are and why they matter. International collaboration: These countries are increasingly participating in international patent agreements, which may influence their approach to patent thickets.

Licensing

The Open Targets Blog

JULY 23, 2025

Finally, the code for the Catalogue is open source, which means researchers can deploy a local version of the Catalogue integrating their own internal data, allowing them to easily compare their results to publicly available data. How have you found the process of developing the Catalogue?

Bioinformatics

Drug Target Review

DECEMBER 9, 2024

DeepMind filed three international (PCT) applications in 2019, which cover relatively broad methods of generating multiple structural predictions, updating parameters using neural networks, and selecting the final structure.

Engineering

The Pharma Data

AUGUST 1, 2025

VoxCell BioInnovation, based in Victoria, British Columbia, has garnered international attention for its development of high-fidelity 3D bioprinted human tissues that mimic real tumors and complex tissue microarchitectures.

Drug Development

Drug Target Review

JUNE 11, 2025

Internally, the models learn to associate concepts, find patterns and relate text and images (or other modalities) so that they can be analysed in the same way. Each modality represents a different type of data, such as text, audio, images, video, and more. The most common MLMs are GPT-4o (powering the free ChatGPT tier), Gemini 1.5

Drugs

Drug Target Review

JUNE 6, 2025

Shared goals in cancer drug discovery For all its internal capabilities, RMX does not operate in isolation. He has authored more than 90 peer reviewed medical manuscripts and presented topics in targeted radionuclide therapies, and PET imaging in multiple national and international congresses.

Therapies

Drug Target Review

JULY 30, 2025

Two technologies, one goal: advancing precision oncology With a background in biochemistry and biology, Julien oversees Orano Med’s internal and external research programmes.

Clinical Trials

The Pharma Data

JUNE 22, 2025

The results from the Phase I/II NXTAGE trial, announced during the 2025 International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington, D.C.,

Clinical Trials

The Pharma Data

JUNE 24, 2025

The strategic funding arrangement is designed to support the continued advancement and global commercialization of Revolution Medicines’ RAS(ON) inhibitor portfolio, including its lead candidate daraxonrasib, as the company scales its operations independently across the international oncology market.

Drug Development

The Pharma Data

JUNE 18, 2025

Following his residency in Internal Medicine at UCSF, Dr. Garg was selected as a fellow in the prestigious Robert Wood Johnson Clinical Scholars Program at Johns Hopkins University. He holds a B.A. in Biochemistry with high honors from the University of California, Berkeley, and earned his medical degree (M.D.)

RNA

Alta Sciences

JUNE 6, 2025

Manually labeling tubes for sample collection is a repetitive task, and automating the process saves significant time while preparing assay tubes used internally, or when preparing clinical sample collection kits.

Pharmacokinetics

Broad Institute

JULY 31, 2025

Gillette said the study shows the power of international collaboration and large-scale genomic and proteomic analysis of cancer, which may pave the way toward better clinical care.& These factors include a pattern of DNA damage and signatures of exposures to chemicals found in processed foods and cosmetics. &

DNA

Drug Target Review

NOVEMBER 11, 2024

This progress has been facilitated using internal technologies to isolate binders with desired properties and engineer functional and developable bispecific antibody molecules. In this way, the tumour can be tricked into telling the immune system how best to effectively attack the tumour cells.

Immune Response

Drug Patent Watch

DECEMBER 9, 2024

Balancing Innovation and Access The intersection of pharmacognosy and drug patents raises important questions about balancing innovation incentives with global access to medicines.

Drugs

PPD

DECEMBER 16, 2024

Rising costs have become a persistent challenge for drug developers, driven by a combination of internal and external pressures that have intensified in recent years. Lacking internal expertise or capacity often slows progress, making outsourcing a strategic necessity.

Drug Development

Drug Patent Watch

DECEMBER 10, 2024

The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines. India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs.

Government

Drug Target Review

AUGUST 12, 2025

He joined Syngene International Ltd, where he led several research projects in research services and integrated drug discovery, working across various target classes towards therapeutic discovery. He has experience with small molecules and expanding modalities such as peptides, PROTACs, and drug conjugates (XDCs).

Drug Development

Pharma Manufacturing

JUNE 17, 2025

Dubey asserts that end-to-end continuous manufacturing is “very rare” and frankly not needed, pointing to the International Council for Harmonization (ICH) Q13 guidance, Continuous Manufacturing of Drug Substances and Drug Products.

RNA

The Pharma Data

JUNE 22, 2025

Novo Nordisk Unveils Positive Phase 3b Results for Mim8 in Hemophilia A: Seamless Switch from Emicizumab Shows Safety, Efficacy, and High Patient Satisfaction Novo Nordisk presented new findings from its pivotal phase 3b FRONTIER5 clinical trial at the 2025 International Society on Thrombosis and Haemostasis (ISTH) Congress, revealing that patients (..)

Pharmacokinetics

The Pharma Data

JUNE 13, 2025

Furthermore, additional data from these ongoing trials will be presented at the 2025 International Conference on Malignant Lymphoma, which is scheduled to take place from June 17–21. This trial aims to further validate the promise of the therapy in patients with relapsed or refractory large B-cell lymphoma. Source link

Therapies

The Pharma Data

JUNE 13, 2025

“Through this collaboration with Astellas, we aim to enable promising Japanese biotechnology companies to accelerate their path toward commercial application by strengthening their international competitiveness.”

Research

The Pharma Data

JUNE 27, 2025

The full dataset is expected to be presented at an upcoming international scientific conference, which will provide greater clarity on the magnitude of fenfluramine’s clinical benefits.

Trials

Perficient: Drug Development

NOVEMBER 20, 2024

Examples include: What is your baggage policy for international flights Can you provide details about your frequent flyer program? What are the requirements for traveling with a pet? Booking Issues Emails under this intent are related to the booking process or flight details.

Engineering

FDA Law Blog: Drug Discovery

APRIL 21, 2025

Senior officials have left, others havent been replaced, and internal morale is reportedly a work in progressa euphemism that, frankly, isnt very euphemistic. Thats all bad news if your timeline depends on FDA sticking to theirs.

FDA